π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The study is being conducted to evaluate the tolerability, safety and effic...
Status
Terminated
Location
Anhui Provincial Hospital
Start Date
2020-08-19
Trial ID
NCT04300114
Treatments Being Tested
The study is being conducted to: a) evaluate the tolerability and safety of...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2020-12-17
Trial ID
NCT04425876
Treatments Being Tested
This study is a prospective, multi-cohort, single-centre, phase II clinical...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06055166
This study was designed to explore the safety and efficacy of Bevacizumab c...
Status
Unknown
Location
The Second Affiliated Hospital of Shandong First Medical University
Start Date
2021-12-24
Trial ID
NCT05170594
Treatments Being Tested
This study is a Phase II randomized, open label, controlled, multicenter st...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-08-01
Trial ID
NCT05479487
Treatments Being Tested
Breast cancer is the most common malignancy in women; approximately 5-10% a...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-01-20
Trial ID
NCT07321015
Treatments Being Tested
Main research purpose: To evaluate the effectiveness of Fluzoparib combined...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-07-19
Trial ID
NCT04869488
This study is an interventional, single-arm, open-label clinical trial. To ...
Status
Unknown
Location
Qilu Hospital of Shandong University
Start Date
2024-06-18
Trial ID
NCT06541314
Treatments Being Tested
This study is an open-label, single-arm, multicenter clinical study. 64 pat...
Status
Recruiting
Location
Breast Cancer, Peking University People's Hospital
Start Date
2022-10-01
Trial ID
NCT05576389
Treatments Being Tested
Ovarian cancer is one of the most fatal malignant tumors that threaten wome...
Status
Recruiting
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-01-14
Trial ID
NCT05206890
Treatments Being Tested